What you need to know about point-of-care (POCT)
Point-of-care testing (POCT) is the rapid testing of biological samples (such as blood, urine, saliva, breath gas, etc.) at the patient's side, using simple instruments or reagents, and results can be obtained within minutes to hours. The test can help physicians make timely diagnosis and treatment plans, and provide important information to improve treatment outcomes in an emergency setting.
Features
1. Fast: POCT often provide results within minutes, allowing people to know their condition immediately.
2. Convenience: POCT is usually done using portable devices and can be performed outside of a medical facility.
3. Accuracy: Although POCT may produce some errors compared with traditional detection methods, these errors are usually controlled within a very small range.
4. Practical: POCT products are available in many disease fields, and can be used for surveillance.
5. Accessibility: POCT products are generally relatively inexpensive, easier to access and use than traditional tests, which makes health service more available.
Applications
POCT applications cover many fields such as healthcare, environment, food safety and agriculture. In the medical field, POCT can be used for early diagnosis, treatment monitoring and disease prevention. For example, in the early diagnosis of myocardial infarction, rapid screening for myocardial enzymes or troponins can be used. In the diagnosis of infectious diseases, rapid diagnostic kits can be used, such as influenza virus rapid diagnostic reagent, tuberculosis antibody rapid diagnostic reagent, etc.
POCT industry has a promising future
With the aging of the population and the increasing number of patients with chronic diseases, POCT provides efficient and accurate detection services and has attracted wide attention. Governments of various countries have also increased their investment and policy support in the POCT field, further promoting the development of POCT technology. In the future, POCT products may penetrate into every corner of people's lives just like mobile phones, computers and other digital products. Small and foolproof automatic detection system will be seen everywhere and available at any time, becoming a necessity for the on-site detection, and family health management.
As a high-tech company engaged in R&D, production and sales of rapid diagnostic reagents and instruments, WIZ focuses on technological innovation and develops POCT testing reagents and instruments. Up to now, the company has factory area of 26,000 square meters and nearly 1,600 square meters of research and development center. WIZ has a mature immune chromatography technology platform, more than 80 certified reagents, covering novel coronavirus, gastrointestinal function, infection, infectious disease, hepatitis, AIDS and other series of products. In addition, the company has made significant progress in the layout of chemiluminescence, microfluidic platforms, molecular diagnostics and other technology platforms. At present, the company's products have entered more than 100 third-level terminal hospitals in China and exported to Germany, Italy, Spain, Finland, Netherlands, Indonesia, Malaysia, Peru and other countries. The company has developed strategic cooperation with Abbott, one of the world's top 500 companies and a leading enterprise in the field of in vitro diagnosis, and become the cooperative institution of Abbott rapid diagnosis in China.
